Short Therapy for Febrile UTI in Childhood

  • STATUS
    Recruiting
  • participants needed
    520
  • sponsor
    IRCCS Burlo Garofolo
Updated on 19 February 2024
antibiotic
antibiotics
antibiotic therapy
fever
urine culture
urinary catheterization
nitrite
leukocyte esterase
clavulanic acid
urinary tract infection
cephalosporins
pediatric
acid vs

Summary

Febrile urinary tract infections (UTIs) are common in children, but there is no consensus concerning the duration of the antibiotic treatment. Current recommendations include the use of an oral antibiotic, chosen between amoxicillin and clavulanic acid or a third-generation cephalosporin (ceftibuten), for a minimum of seven to a maximum of 14 days. In an antibiotic overuse-sparing model, proper evaluation of a shorter therapy in the treatment of febrile UTI in childhood is lacking.

The objective of this randomized controlled trial is to assess the non inferiority of a five days oral course of amoxicillin and clavulanic acid vs the standard 10-day regimen in the treatment of febrile UTIs in children.

The trial results might provide evidence of the non-inferiority of a short duration of the antibiotic course for the treatment of febrile UTI in childhood, contributing to a reduction in the over-use of antibiotics and consequently limiting the emergence of antibiotic resistance.

Details
Condition Urinary tract infection
Age 1-5 years
Treatment Amoxicillin and Clavulanic Acid in Oral Dose Form
Clinical Study IdentifierNCT04400110
SponsorIRCCS Burlo Garofolo
Last Modified on19 February 2024

Eligibility

Yes No Not Sure

Inclusion Criteria

Age from 3 months to 5 years
Clinical diagnosis of febrile UTI, defined by fever 38C and positive result of urinalysis (nitrite and/or leukocyte esterase positivity) in two consecutive urine samples collected by bladder catheterization or clean catch (19). The diagnosis of UTI will be then confirmed by positive urine culture for a single type of bacterium with a charge> 105 CFU /ml as per the Recommendations of the Italian Society of Pediatric Nephrology (SINePe) (19)

Exclusion Criteria

Complicated" febrile UTI (septic appearance, repeated vomiting impeding oral administration of the antibiotic, severe-moderate dehydration with the need for intravenous antibiotic therapy)
Presence of an inserted urinary catheter
Immunodeficiency
Hypersensitivity to the active substance or other beta-lactam antibiotics
Any antibiotic treatment received in the previous 15 days
Presence of another poorly controlled chronic medical condition (diabetes, inflammatory bowel disease, etc.)
Presence of neurological bladder
Presence of phenylketonuria or glucose-galactose malabsorption
Intestinal malabsorption
Poor compliance
History of jaundice or liver failure positive
Clear my responses

How to participate?

Step 1 Connect with a study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Loading...

Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 

 • 

Private

Reply by • Private
Loading...

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.
Loading...

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.